{"id":"im-ketamine","safety":{"commonSideEffects":[{"rate":null,"effect":"Dissociation"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Increased blood pressure"},{"rate":null,"effect":"Tachycardia"}]},"_chembl":{"chemblId":"CHEMBL742","moleculeType":"Small molecule","molecularWeight":"237.73"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ketamine blocks NMDA glutamate receptors in the central nervous system, leading to dissociation, anesthesia, and analgesia. The intramuscular formulation provides a non-intravenous route of administration for acute pain management and sedation. In psychiatric applications, ketamine's rapid effects on glutamatergic neurotransmission may contribute to fast-acting antidepressant and anti-suicidal ideation effects.","oneSentence":"IM Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist administered intramuscularly that produces rapid-onset dissociative anesthesia and analgesia.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:33.238Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment-resistant depression"},{"name":"Acute suicidal ideation"},{"name":"Acute pain management"}]},"trialDetails":[{"nctId":"NCT07276542","phase":"PHASE2, PHASE3","title":"Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.","status":"RECRUITING","sponsor":"The Ketamine Research Foundation","startDate":"2026-01-15","conditions":"Phantom Limb Syndrome With Pain","enrollment":30},{"nctId":"NCT07059429","phase":"NA","title":"Ketamine Administration for Postoperative Pain Management in Patients Undergoing Knee Arthroplasty","status":"COMPLETED","sponsor":"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia","startDate":"2025-07-01","conditions":"Knee Arthroplasty, Postoperative Pain, Pain Management","enrollment":100},{"nctId":"NCT06821087","phase":"PHASE2","title":"Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas at Austin","startDate":"2025-04-28","conditions":"Long COVID","enrollment":20},{"nctId":"NCT07247006","phase":"PHASE2","title":"Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2026-01","conditions":"Treatment Resistant Depression (TRD), Chronic Pain","enrollment":25},{"nctId":"NCT07086690","phase":"PHASE1","title":"Comparing Nebulized Ketamine,Nebulized Ketamine and Precedex and IM Ketamine for Analgesia in Pediatric Burn","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-04-16","conditions":"Inhalation Anesthesia","enrollment":60},{"nctId":"NCT05796791","phase":"EARLY_PHASE1","title":"Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2023-05-02","conditions":"Tobacco Use, Smoking Cessation, Nicotine Dependence","enrollment":7},{"nctId":"NCT06559826","phase":"PHASE2","title":"Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2025-01-10","conditions":"Major Depressive Disorder","enrollment":70},{"nctId":"NCT06077487","phase":"PHASE4","title":"Ketamine-assisted Therapy for Advanced GI Cancer","status":"TERMINATED","sponsor":"Brian Anderson, MD","startDate":"2024-05-17","conditions":"Pancreatic Ductal Adenocarcinoma, Pain, Acute, Gastrointestinal Cancers","enrollment":1},{"nctId":"NCT04640636","phase":"PHASE4","title":"IM Ketamine vs Midazolam for Suicidal ER Patients","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2021-02-09","conditions":"Depression, Unipolar, Depression, Bipolar, Suicidal Ideation","enrollment":90},{"nctId":"NCT05696691","phase":"PHASE2, PHASE3","title":"Ketamine & Crisis Response Plan for Suicidal Ideation in the ED","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2023-01-06","conditions":"Suicide","enrollment":24},{"nctId":"NCT06538285","phase":"PHASE2","title":"Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV","status":"RECRUITING","sponsor":"Nicky Mehtani, MD, MPH","startDate":"2025-03-04","conditions":"Methamphetamine Use Disorder","enrollment":12},{"nctId":"NCT04894864","phase":"PHASE4","title":"Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair","status":"RECRUITING","sponsor":"University of Crete","startDate":"2020-10-08","conditions":"Elective Surgical Procedures, Postoperative Pain, Anesthesia","enrollment":40},{"nctId":"NCT06036511","phase":"PHASE1, PHASE2","title":"Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD","status":"WITHDRAWN","sponsor":"University of New Mexico","startDate":"2023-12-31","conditions":"PTSD","enrollment":""},{"nctId":"NCT05565664","phase":"PHASE4","title":"Ketamine Versus Magnesium as Analgesic Adjuvants in Pediatric Adenotonsillectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-11-01","conditions":"Post Operative Pain, Acute","enrollment":38},{"nctId":"NCT04508894","phase":"NA","title":"Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block","status":"COMPLETED","sponsor":"Minia University","startDate":"2019-04-21","conditions":"Supraclavicular Brachial Plexus Block","enrollment":75},{"nctId":"NCT05670561","phase":"PHASE4","title":"Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2023-01-05","conditions":"Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain","enrollment":60},{"nctId":"NCT05416073","phase":"PHASE4","title":"Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2022-06-22","conditions":"Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemotherapy","enrollment":70},{"nctId":"NCT05105061","phase":"PHASE2","title":"Intramuscular Ketamine for Suicidal Ideation","status":"WITHDRAWN","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2022-02","conditions":"Suicidal Ideation","enrollment":""},{"nctId":"NCT05214417","phase":"PHASE2","title":"Conscious Dying/Conscious Living: Ketamine-Assisted Psychotherapy","status":"UNKNOWN","sponsor":"The Ketamine Research Foundation","startDate":"2022-05-01","conditions":"Illness Terminal","enrollment":120},{"nctId":"NCT05172739","phase":"PHASE4","title":"Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC","status":"RECRUITING","sponsor":"University of Crete","startDate":"2021-10-01","conditions":"Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic","enrollment":70},{"nctId":"NCT04285684","phase":"EARLY_PHASE1","title":"The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women","status":"COMPLETED","sponsor":"The Ketamine Research Foundation","startDate":"2019-12-20","conditions":"Ketamine, Lactation","enrollment":4},{"nctId":"NCT03375671","phase":"PHASE2","title":"Rapid Agitation Control With Ketamine in the Emergency Department","status":"COMPLETED","sponsor":"David Barbic","startDate":"2018-05-29","conditions":"Violent Aggressive Behavior, Ketamine","enrollment":81},{"nctId":"NCT04234776","phase":"PHASE4","title":"Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2018-04-03","conditions":"Depressive Disorder","enrollment":88},{"nctId":"NCT04021433","phase":"NA","title":"Ketamine for Treatment Resistant MDD","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2018-09-01","conditions":"Depressive Disorder, Major","enrollment":20},{"nctId":"NCT04013958","phase":"PHASE3","title":"Comparison of Treatment by IM Ketamine to IV Ketamine in Patients With Renal Colic","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2019-08-01","conditions":"Acute Pain, Renal Colic","enrollment":100},{"nctId":"NCT03860831","phase":"PHASE1","title":"Intranasal Ketamine and Midazolam Mixture for Procedural Sedation in Children With Mental Disabilities:","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2019-03-06","conditions":"Procedural Sedation","enrollment":40},{"nctId":"NCT03671070","phase":"NA","title":"Role of Low Dose Epinephrine Boluses In Acute Hypotension","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-01-01","conditions":"Hypotension and Shock","enrollment":50},{"nctId":"NCT03216941","phase":"PHASE4","title":"Randomised Trial Ketiapine Olanzapine Fast Sedation Agitated Patients Emergency Ward","status":"COMPLETED","sponsor":"Universidad Nacional de Rosario","startDate":"2015-01-01","conditions":"Psychomotor Agitation, Psychiatric Disorder, Emergency Psychiatric","enrollment":500},{"nctId":"NCT02817477","phase":"PHASE4","title":"Intranasal Ketamine for Acute Traumatic Pain","status":"COMPLETED","sponsor":"Tel Aviv Medical Center","startDate":"2012-09","conditions":"Acute Pain","enrollment":90},{"nctId":"NCT01441505","phase":"PHASE2","title":"A Study of Ketamine as an Antidepressant","status":"UNKNOWN","sponsor":"The University of New South Wales","startDate":"2011-09","conditions":"Major Depressive Episode","enrollment":42},{"nctId":"NCT01070108","phase":"NA","title":"Escalating Ketamine Doses and Pre-emption","status":"COMPLETED","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2007-01","conditions":"Postoperative Pain Management","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":71,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IM Ketamine","genericName":"IM Ketamine","companyName":"Tel-Aviv Sourasky Medical Center","companyId":"tel-aviv-sourasky-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"IM Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist administered intramuscularly that produces rapid-onset dissociative anesthesia and analgesia. Used for Treatment-resistant depression, Acute suicidal ideation, Acute pain management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}